Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses
Arindam Bhattacharjee, William G. Richards, Jane E. Staunton et al. · Proceedings of the National Academy of Sciences · 2001
We have generated a molecular taxonomy of lung carcinoma, the leading cause of cancer death in the United States and worldwide. Using oligonucleotide microarrays, we analyzed mRNA expression levels corresponding to 12,600 transcript sequences in 186 lung tumor samples, including 139 adenocarcinomas resected from the lung. Hierarchical and probabilistic clustering of expression data defined distinct subclasses of lung adenocarcinoma. Among these were tumors with high relative expression of neuroendocrine genes and of type II pneumocyte genes, respectively. Retrospective analysis revealed a less favorable outcome for the adenocarcinomas with neuroendocrine gene expression. The diagnostic potential of expression profiling is emphasized by its ability to discriminate primary lung adenocarcinomas from metastases of extra-pulmonary origin. These results suggest that integration of expression profile data with clinical parameters could aid in diagnosis of lung cancer patients.
Cited by 2,576 works. doi:10.1073/pnas.191502998
Authors
- Arindam Bhattacharjee
- William G. Richards
- Jane E. Staunton
- Cheng Li
- Stefano Monti
- Priya P Vasa
- Javad Beheshti
- Raphael Bueno
- Michael A. Gillette
- Massimo F. Loda
- Griffin M. Weber
- Eugene Jerome Mark
- Eric S. Lander
- Wing Hung Wong
- Bruce Evan Johnson
- Todd R. Golub
- David J. Sugarbaker
- Matthew M. Meyerson
References
- Cluster analysis and display of genome-wide expression patterns
- Quantitative Monitoring of Gene Expression Patterns with a Complementary DNA Microarray
- Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring
- Molecular portraits of human breast tumours
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
- Expression monitoring by hybridization to high-density oligonucleotide arrays
- Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia
- Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
- Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays
- Advances in knowledge discovery and data mining